Biopharmacetiucal Approval Trends in 2009 - Biotech approvals were up last year. Is it a sign of a new trend? - BioPharm International

ADVERTISEMENT

Biopharmacetiucal Approval Trends in 2009
Biotech approvals were up last year. Is it a sign of a new trend?


BioPharm International
Volume 23, Issue 10

REFERENCES

1. The future of the biological market. Business insights report. 2010 Mar. Available from: http://www.globalbusinessinsights.com/

2. Carlson B. Biosimilar market fails to meet projections. Gen Eng Biotechnol News. 2009;29:43–5.

3. US Food and Drug Administration. CDER drug and biologic calendar year approvals. 2009 Dec 31. Available from: http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/DrugandBiologicApprovalReports/PriorityNDAandBLAApprovals/UCM090995.pdf 4.

4. European Medicines Agency. Available from: http://www.ema.europa.eu/ema

5. Walsh G. Biopharmaceuticals: approvals and approval trends in 2008. Biopharm Int. 2009;22(10):68–77.

6. Walsh G. Biopharmaceuticals: approval trends in 2007. BioPharm Int. 2008;21(10):52–65.

7. Walsh G. Biopharmaceuticals: approval trends in 2006. BioPharm Int. 2007;20(10):56–67.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
IMS: Global Spending on Medicines to Rise 30% by 2018
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here